Related references
Note: Only part of the references are listed.Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation
Evelyn N. Kouwenhoven et al.
EMBO REPORTS (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
MicroRNAs and p63 in epithelial stemness
E. Candi et al.
CELL DEATH AND DIFFERENTIATION (2015)
Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes
Isha Sethi et al.
BMC GENOMICS (2014)
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Arianna Sabo et al.
NATURE (2014)
Transcriptional enhancers: from properties to genome-wide predictions
Daria Shlyueva et al.
NATURE REVIEWS GENETICS (2014)
Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress
Simon S. McDade et al.
NUCLEIC ACIDS RESEARCH (2014)
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
Joel P. Charles et al.
NATURE COMMUNICATIONS (2014)
Mesoporous silicon sponge as an anti-pulverization structure for high-performance lithium-ion battery anodes
Xiaolin Li et al.
NATURE COMMUNICATIONS (2014)
p63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells
Daniela Montariello et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks
Changxian Shen et al.
CANCER RESEARCH (2013)
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma
Matthew R. Ramsey et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
New Radiotherapy and Chemoradiotherapy Approaches for Non-Small-Cell Lung Cancer
Joseph K. Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
FANCD2 Activates Transcription of TAp63 and Suppresses Tumorigenesis
Eunmi Park et al.
MOLECULAR CELL (2013)
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks
Molly C. Kottemann et al.
NATURE (2013)
ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63
Luca Tordella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63
Kathryn E. King et al.
JOURNAL OF SKIN CANCER (2013)
Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
K. Hirashima et al.
BRITISH JOURNAL OF CANCER (2012)
Global tumor protein p53/p63 interactome Making a case for cisplatin chemoresistance
Yiping Huang et al.
CELL CYCLE (2012)
Phospho-ΔNp63α/SREBF1 protein interactions Bridging cell metabolism and cisplatin chemoresistance
Yiping Huang et al.
CELL CYCLE (2012)
TAp63γ enhances nucleotide excision repair through transcriptional regulation of DNA repair genes
Juan Liu et al.
DNA REPAIR (2012)
ΔNp63α represses anti-proliferative genes via H2A.Z deposition
Corrie L. Gallant-Behm et al.
GENES & DEVELOPMENT (2012)
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Hyungjin Kim et al.
GENES & DEVELOPMENT (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Color-coded real-time imaging of the interaction of mesenchymal stem cells and cancer cells
James Ke et al.
CANCER RESEARCH (2011)
ΔNp63α Confers Tumor Cell Resistance to Cisplatin through the AKT1 Transcriptional Regulation
Tanusree Sen et al.
CANCER RESEARCH (2011)
ΔNp63 Versatilely Regulates a Broad NF-κB Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation
Xinping Yang et al.
CANCER RESEARCH (2011)
p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
G. Melino
CELL DEATH AND DIFFERENTIATION (2011)
ΔNp630α Is an Oncogene that Targets Chromatin Remodeler Lsh to Drive Skin Stem Cell Proliferation and Tumorigenesis
William M. Keyes et al.
CELL STEM CELL (2011)
Loss of ΔNp63α promotes mitotic exit in epithelial cells
Pok Man Hau et al.
FEBS LETTERS (2011)
Mapping and analysis of chromatin state dynamics in nine human cell types
Jason Ernst et al.
NATURE (2011)
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
Kristen L. Meerbrey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
DNA interstrand crosslink repair and cancer
Andrew J. Deans et al.
NATURE REVIEWS CANCER (2011)
mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice
Guiqin Hou et al.
CANCER LETTERS (2010)
DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Katharina Schlereth et al.
MOLECULAR CELL (2010)
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico et al.
PLOS ONE (2010)
c-Abl phosphorylation of Delta Np63 alpha is critical for cell viability
M. Yuan et al.
CELL DEATH & DISEASE (2010)
Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia Phenotype
Jung Min Kim et al.
DEVELOPMENTAL CELL (2009)
Differences in the Nemosis Response of Normal and Cancer-Associated Fibroblasts from Patients with Oral Squamous Cell Carcinoma
Kati Rasanen et al.
PLOS ONE (2009)
p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair
Yu-Li Lin et al.
PLOS GENETICS (2009)
U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of ΔNp63α
Aditi Chatterjee et al.
CELL CYCLE (2008)
C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity
Markus Sauer et al.
NUCLEIC ACIDS RESEARCH (2008)
Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63
Bridget E. Ferguson-Yates et al.
CARCINOGENESIS (2008)
A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway
Martin A. Cohn et al.
MOLECULAR CELL (2007)
Deubiquitination of FANCD2 is required for DNA crosslink repair
Vibe H. Oestergaard et al.
MOLECULAR CELL (2007)
p63 is essential for the proliferative potential of stem cells in stratified epithelia
Makoto Senoo et al.
CELL (2007)
Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma
Maurice Phillip DeYoung et al.
CANCER RESEARCH (2006)
p63 regulates an adhesion programme and cell survival in epithelial cells
Danielle K. Carroll et al.
NATURE CELL BIOLOGY (2006)
Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei
B Liedert et al.
NUCLEIC ACIDS RESEARCH (2006)
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
JW Rocco et al.
CANCER CELL (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ΔNp63α levels correlate with clinical tumor response to cisplatin
R Zangen et al.
CELL CYCLE (2005)
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway
SMB Nijman et al.
MOLECULAR CELL (2005)
MGMT: Its role in cancer aetiology and cancer therapeutics
SL Gerson
NATURE REVIEWS CANCER (2004)
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice
S Houghtaling et al.
GENES & DEVELOPMENT (2003)
AIS is an oncogene amplified in squamous cell carcinoma
K Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
